Scientific article
English

HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy

Published in

Clinical infectious diseases, vol. 46, no. 12, p. 1921-1925

Publication date

2008

Abstract

We assessed the influence of human leukocyte antigen (HLA) alleles HLA-Bw4 and HLA-Bw6 on CD4 T cell recovery after starting successful combination antiretroviral therapy in 265 individuals. The median gains in the CD4 T cell count after 4 years were 258 cells/microL for HLA-Bw4 homozygotes, 321 cells/microL for HLA-Bw4/Bw6 heterozygotes, and 363 cells/microL for HLA-Bw6 homozygotes (P =.01, compared with HLA-Bw4 homozygotes). HLA-Bw4 homozygosity appears to predict an impaired CD4 T cell recovery after initiation of combination antiretroviral therapy.

Keywords

  • Adult
  • Aged
  • Aged, 80 and over
  • Antiretroviral Therapy, Highly Active
  • CD4 Lymphocyte Count
  • CD4-Positive T-Lymphocytes/immunology
  • Female
  • HIV Infections/drug therapy/genetics/immunology
  • HLA-B Antigens/genetics
  • Homozygote
  • Humans
  • Male
  • Middle Aged

UNIGE research groups

Citation (ISO format)

RAUCH, Andri et al. HLA-Bw4 homozygosity is associated with an impaired CD4 T cell recovery after initiation of antiretroviral therapy. In: Clinical infectious diseases, 2008, vol. 46, n° 12, p. 1921–1925. doi: 10.1086/588479

Main files (1)

Article (Accepted version)

Identifiers

Journal ISSN

1058-4838
568views
0downloads

Technical informations

Creation

18/06/2009 15:15:00

First validation

18/06/2009 15:15:00

Update

30/03/2023 09:40:40

Status update

30/03/2023 09:40:39

Last indexation

29/10/2024 11:45:21
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated